
This exclusive medical education activity is designed for healthcare professionals specializing in diabetes care and management. This webinar series will provide an in-depth exploration of the advancements in basal insulins, with a particular focus on Insulin Degludec.
THEME: The Evolution of Basal Insulins: Insulin Degludec - Approaching Physiology
In this webinar series, we will delve into the transformative journey of basal insulins, focusing on Insulin Degludec, which is designed to closely mimic physiological insulin secretion. Our expert endocrinologist will provide a thorough examination of how these innovations are reshaping diabetes management, offering improved control and outcomes for patients.
Join us for an engaging and informative session to explore the cutting-edge developments and future directions in basal insulin therapy, led by a distinguished endocrinologist. The presentation will cover critical topics such as:
i. An overview of diabetes epidemiology
ii. The evolution of basal insulins
iii. Identifying the ideal basal insulin
iv. Addressing the unmet needs of basal insulins
v. Evaluating cardiovascular outcomes and the health economic value of basal insulins
The webinar will conclude with a highly interactive question and answer session, allowing participants to engage directly with the expert.
WHY ATTEND
SUPPORTED BY
This will be a LIVE virtual event. Thursday the 27th of June 2024. This event will be streamed live on this page.
Date: Thursday the 27th of June 2024
Time: 1630 - 1800 GMT (4:30-6:00 pm Local Time)
Target Audience: Healthcare Professionals
The agenda is available to download in the downloads section.
The NOVO NORDISK BASAL INSULIN SUMMIT, is an exclusive live webinar series designed for healthcare professionals. This event, led by a highly experienced and accomplished endocrinologist, will explore the evolution of basal insulins with a focus on Insulin Degludec. Participants will gain insights into diabetes epidemiology, advancements in basal insulin therapy, the characteristics of an ideal basal insulin, unmet clinical needs, and the cardiovascular and economic impacts of these treatments. The summit will feature a comprehensive presentation followed by an interactive Q&A session, providing an invaluable opportunity for professional development and knowledge enhancement.
After participating in the NOVO NORDISK BASAL INSULIN SUMMIT, healthcare professionals are expected to:
1. Review the current state of diabetes epidemiology.
2. Trace the development and advancements in basal insulins.
3. Identify characteristics of the ideal basal insulin.
4. Address the unmet clinical needs in basal insulin therapy.
5. Evaluate the cardiovascular and economic impacts of basal insulin treatments.
BSc, MBChB, MSc, PGDip, Endo., Cert. HAM, FWACP, MAACE.
Senior Lecturer || Consultant Physician || Diabetologist || Endocrinologist
University of Ghana Medical School || National Diabetes Management and Research Centre (NDMRC) || Korle Bu Teaching Hospital in Accra, Ghana.
Dr. Yacoba Atiase is a distinguished consultant endocrinologist and diabetologist at the Korle Bu Teaching Hospital in Accra, Ghana. She also holds a senior lecturer position at the University of Ghana Medical School and serves as the Director of the National Diabetes Management and Research Center (NDMRC).
View full profile / courses